The AtaCor EV Temporary Pacing System
AN INSIDE JOB
THAT’S OUTSIDE THE HEART.
First of its kind, the innovative AtaCor EV Temporary Pacing System is advancing the standard of cardiac pacing. It is the only implantable temporary pacing system designed to leave the heart and vascular system completely untouched—for prompt pacing support without the discomfort, risk, and limitations of traditional methods.

PLACE IT BELOW THE STERNUM.
PACE IT ABOVE THE HEART.

The custom StealthTrac Lead connects to any commercially-available external pacemaker.
Using a proprietary parasternal approach, the AtaCor EV Temporary Pacing System advances a custom pacing lead into the extracardiac tissue between the ribs and pericardium.
By harnessing the human anatomy, the AtaCor EV Temporary Pacing System is engineered to provide reliable pacing support while eliminating the risks and complexity of transvenous pacing.
TEMPORARY PACING BEYOND THE
CATH LAB–AND BEYOND EXPECTATIONS.

TIMELY PROTECTION
WITHOUT THE DISCOMFORT.

EXTRAVASCULAR ACCESS FOR
REDUCED BEDREST RESTRICTIONS.

In addition to streamlining delivery of temporary pacing, the AtaCor EV Temporary Pacing System’s extravascular implantation is designed to remove bedrest restrictions, speeding patient recovery and shortening hospital length-of-stay:
- Supports safe post-procedure patient ambulation
- Enables patient transfer to non-ICU bed for extended evaluation
- Reduces need for ICU observation and related nursing resources, decreasing cost-of-care
SIMPLIFYING PATIENT MANAGEMENT
DURING AND AFTER TAVR
TAVR procedures are on the rise—and expected to increase as the population ages and procedure indications expand to younger and healthier patients.1 The AtaCor EV Temporary Pacing System is designed to support stable extravascular and extracardiac pacing during valve deployment and postoperative evaluation for conduction disturbances, for streamlined TAVR patient management and recovery:
- Enables preoperative lead insertion which may shorten overall procedure length
- Connects to commercially-available external temporary pacemakers
- Eliminates transvenous pacing leads
- Reduces vascular access management and complications
- Enables safe post-procedure patient ambulation
- Eliminates bedrest restrictions, reducing ICU and related nursing costs

SIMPLIFYING PATIENT MANAGEMENT
AFTER MYOCARDIAL INFARCTION
Conduction abnormalities, whether transitory or persistent, develop in approximately 90% of patients who experience a myocardial infarction.2 The AtaCor EV Temporary Pacing System is designed to support stable pacing of new-onset arrhythmias to help guide treatment decisions and optimize patient care:
- Enables evaluation of conduction disturbances to determine the need for permanent pacing
- Enables safe post-procedure patient ambulation
- Eliminates bedrest restrictions, reducing ICU and related nursing costs
- Carroll JD. TAVR prognosis, aging, and the second TAVR tsunami: insights from France. J Am Coll Cardiol. 2016;68(15):1648-50.
- Perron AD, Sweeney T. Arrhythmic complications of acute coronary syndromes. Emerg Med Clin North Am. 2005;23(4):1065-1082.
ENGINEERED WITH THE
HUMAN ANATOMY IN MIND.
